Healthcare
Judgment is what the group is paid for. Starch builds the workflows behind your landscape decks, comp sets and buyer lists, so the week goes to clients instead of scrubbing databases.
And the sources and analysis behind each one.
Biopharma does not run a standard auction. Roughly two dozen buyers matter, there are no standard financials, and value turns on what stage the trial is in. The comps come out of the databases inconsistent and get checked against press releases by hand.
| What you use today | What it does well | Where it falls short |
|---|---|---|
| Horizontal AI platforms for finance | Firm-wide search and Q&A across your documents | One product sold to hundreds of firms. It will find the precedent CIM; it will not draft the next one in your format, and every bank pitching against you runs the same thing. |
| General AI assistants | Fast drafting and Q&A on public information | Prompt-only and closed: no access to internal files, no search across past presentations, no memory of what the group has already built. |
| Healthcare deal databases | Deal comps and pipeline data in one place | Inconsistent enough that every comp gets verified by hand, and asset status and deprioritisations are not in the filters. |
| Horizontal AI platforms | Broad coverage across sectors | The workflows and data sources here are too niche for them, and the context that decides whether a comp is usable, like a distressed sale, cannot be captured in a filter. |
| Junior bankers | Scrubbing comps and building landscape decks | Capacity-bound, and with no internal precedent index, finding a past deck means guessing at company folders three at a time. |
Nothing on the market produces this work the way your group produces it.
Starch is built for this coverage group, on your own precedent.
We work with more than one firm and we would rather say so. What we will not do is hand another team your build. The software is built against your precedent, your formats and your standard for finished work, and those are not things a competitor can license.
It also does not stand still. Every mandate leaves precedent behind and the next CIM starts from it. A platform hundreds of firms share is as good on day one as it will ever be for you. Yours keeps pulling away.
The curve has a start date. A team that begins now is building something the team that waits will spend years catching up to.
Thirty minutes, on the work your group actually produces.